292 related articles for article (PubMed ID: 12397021)
1. Involvement of microbial components and toll-like receptors 2 and 4 in cytokine responses to air pollution particles.
Becker S; Fenton MJ; Soukup JM
Am J Respir Cell Mol Biol; 2002 Nov; 27(5):611-8. PubMed ID: 12397021
[TBL] [Abstract][Full Text] [Related]
2. TLR-2 is involved in airway epithelial cell response to air pollution particles.
Becker S; Dailey L; Soukup JM; Silbajoris R; Devlin RB
Toxicol Appl Pharmacol; 2005 Feb; 203(1):45-52. PubMed ID: 15694463
[TBL] [Abstract][Full Text] [Related]
3. Regulation of cytokine production in human alveolar macrophages and airway epithelial cells in response to ambient air pollution particles: further mechanistic studies.
Becker S; Mundandhara S; Devlin RB; Madden M
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):269-75. PubMed ID: 15993911
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses.
Means TK; Jones BW; Schromm AB; Shurtleff BA; Smith JA; Keane J; Golenbock DT; Vogel SN; Fenton MJ
J Immunol; 2001 Mar; 166(6):4074-82. PubMed ID: 11238656
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide.
Lien E; Means TK; Heine H; Yoshimura A; Kusumoto S; Fukase K; Fenton MJ; Oikawa M; Qureshi N; Monks B; Finberg RW; Ingalls RR; Golenbock DT
J Clin Invest; 2000 Feb; 105(4):497-504. PubMed ID: 10683379
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
[TBL] [Abstract][Full Text] [Related]
7. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2.
Schwandner R; Dziarski R; Wesche H; Rothe M; Kirschning CJ
J Biol Chem; 1999 Jun; 274(25):17406-9. PubMed ID: 10364168
[TBL] [Abstract][Full Text] [Related]
8. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14.
Ellingsen E; Morath S; Flo T; Schromm A; Hartung T; Thiemermann C; Espevik T; Golenbock D; Foster D; Solberg R; Aasen A; Wang J
Med Sci Monit; 2002 May; 8(5):BR149-56. PubMed ID: 12011760
[TBL] [Abstract][Full Text] [Related]
9. Expression of functional Toll-like receptor 2 on human epidermal keratinocytes.
Kawai K; Shimura H; Minagawa M; Ito A; Tomiyama K; Ito M
J Dermatol Sci; 2002 Dec; 30(3):185-94. PubMed ID: 12443841
[TBL] [Abstract][Full Text] [Related]
10. Involvement of lipopolysaccharide binding protein, CD14, and Toll-like receptors in the initiation of innate immune responses by Treponema glycolipids.
Schröder NW; Opitz B; Lamping N; Michelsen KS; Zähringer U; Göbel UB; Schumann RR
J Immunol; 2000 Sep; 165(5):2683-93. PubMed ID: 10946299
[TBL] [Abstract][Full Text] [Related]
11. Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4.
Mandell L; Moran AP; Cocchiarella A; Houghton J; Taylor N; Fox JG; Wang TC; Kurt-Jones EA
Infect Immun; 2004 Nov; 72(11):6446-54. PubMed ID: 15501775
[TBL] [Abstract][Full Text] [Related]
12. Human toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide.
Flo TH; Halaas O; Lien E; Ryan L; Teti G; Golenbock DT; Sundan A; Espevik T
J Immunol; 2000 Feb; 164(4):2064-9. PubMed ID: 10657659
[TBL] [Abstract][Full Text] [Related]
13. Initial responses to endotoxins and Gram-negative bacteria.
Heumann D; Roger T
Clin Chim Acta; 2002 Sep; 323(1-2):59-72. PubMed ID: 12135807
[TBL] [Abstract][Full Text] [Related]
14. Essential roles of CD14 and lipopolysaccharide-binding protein for activation of toll-like receptor (TLR)2 as well as TLR4 Reconstitution of TLR2- and TLR4-activation by distinguishable ligands in LPS preparations.
Muta T; Takeshige K
Eur J Biochem; 2001 Aug; 268(16):4580-9. PubMed ID: 11502220
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses.
Schröder NW; Heine H; Alexander C; Manukyan M; Eckert J; Hamann L; Göbel UB; Schumann RR
J Immunol; 2004 Aug; 173(4):2683-91. PubMed ID: 15294986
[TBL] [Abstract][Full Text] [Related]
16. Human alveolar macrophage responses to air pollution particulates are associated with insoluble components of coarse material, including particulate endotoxin.
Soukup JM; Becker S
Toxicol Appl Pharmacol; 2001 Feb; 171(1):20-6. PubMed ID: 11181108
[TBL] [Abstract][Full Text] [Related]
17. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved.
Schröder NW; Morath S; Alexander C; Hamann L; Hartung T; Zähringer U; Göbel UB; Weber JR; Schumann RR
J Biol Chem; 2003 May; 278(18):15587-94. PubMed ID: 12594207
[TBL] [Abstract][Full Text] [Related]
18. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis.
Means TK; Wang S; Lien E; Yoshimura A; Golenbock DT; Fenton MJ
J Immunol; 1999 Oct; 163(7):3920-7. PubMed ID: 10490993
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14.
Akashi S; Saitoh S; Wakabayashi Y; Kikuchi T; Takamura N; Nagai Y; Kusumoto Y; Fukase K; Kusumoto S; Adachi Y; Kosugi A; Miyake K
J Exp Med; 2003 Oct; 198(7):1035-42. PubMed ID: 14517279
[TBL] [Abstract][Full Text] [Related]
20. A novel synthetic acyclic lipid A-like agonist activates cells via the lipopolysaccharide/toll-like receptor 4 signaling pathway.
Lien E; Chow JC; Hawkins LD; McGuinness PD; Miyake K; Espevik T; Gusovsky F; Golenbock DT
J Biol Chem; 2001 Jan; 276(3):1873-80. PubMed ID: 11032843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
